RNA modification plays a vital role in TDP-43-related neurodegeneration in ALS

Nearly 100% of cases of amyotrophic lateral sclerosis-the progressive, fatal neurodegenerative disease known as ALS or Lou Gherig's disease-involve the buildup of a protein called TDP-43.

Scientists know that TDP-43, which helps regulate processing of RNA, may be responsible for the death of nerve cells in ALS and frontotemporal dementia. Previous studies by investigators at Michigan Medicine found that too much TDP-43 in the cells of patients caused the RNA to become very unstable.

And a study published in Molecular Cell suggests that a common modification to RNA plays a pivotal role in TDP-43-related neurodegeneration in ALS.

Researchers at Michigan Medicine focused on the most abundant RNA modification, a methylation event known as m6A. Through sequencing analysis, investigators showed that methylation strongly influences the binding of TDP-43 to its RNA targets. They also observed highly abundant RNA methylation in the end-stage tissues of patients with ALS.

This is an RNA modification that has escaped our attention in the past, and yet it is rampant in patients with ALS. Despite the fact that we see all this RNA methylation, it's hard to say exactly what it means. It is like watching the end of the movie and then trying to work out the plot. We see RNA methylation, TDP-43 buildup and loss of brain cells, but how are these connected?"

Sami Barmada, MD, PhD, Study Senior Author and Angela Dobson Welch and Lyndon Welch Research Professor, Neurology, University of Michigan Medical School

Previous studies suggest that total levels of m6A in the nervous system rise with age and that (some) neurodegenerative diseases are characterized by RNA hypermethylation. Importantly, RNA methylation is modified by environmental exposure.

Its presence in ALS, Barmada says, opens up a wide range of possibilities for research of a disease that is intimately linked to environmental exposure, as demonstrated by Stephen Goutman, M.D., M.S., and Eva Feldman, M.D., Ph.D., at Michigan Medicine.

Additional authors include Michael McMillan Ph.D., Nicolas Gomez M.S., Caroline Hsieh M.S., Michael Bekier Ph.D., Xingli Li Ph.D., Roberto Miguez M.S. and Elizabeth M. H. Tank Ph.D., all of University of Michigan.

Funding was provided by the NIH/NINDS, NIH/NIA, the family of Angela Dobson Welch and Lyndon Welch, the Robert Packard Center for ALS Research and the Alfred A. Taubman Medical Research Institute.

Barmada is a member of the Scientific Advisory Board for the Robert Packard Center for ALS Research

Source:
Journal reference:

McMillan, M., et al. (2023). RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia. Molecular Cell. doi.org/10.1016/j.molcel.2022.12.019

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cryo-EM Imaging Unveils Similar Protein Structures in Alzheimer's and Down Syndrome